A Safety and Immunogenicity Study of Inactivated SARS-CoV-2 Vaccine (Vero Cells) in Healthy Population Aged 18 Years and Above(COVID-19)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
This study is a randomized, double-blinded, and placebo controlled phase Ⅰ clinical trial of the SARS-CoV-2 inactivated vaccine to evaluate the safety and immunogenicity of the experimental vaccine in healthy adults ⩾18 years.
Epistemonikos ID: 828a557dc70c3ecd41f060b486b9cb04a415f20c
First added on: Feb 18, 2021